6550--Diasorin Liaison XL Analyzer and Testing
Closed Special Notice Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 36C24924Q0274
- Agency
- Veterans Integrated Service Network 9 Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Points of contact
-
- Christina Lawrence christina.lawrence2@va.gov (615) 225-3426
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs (VA) Network Contracting Office 9, on behalf of the Lexington Veterans Affairs Healthcare System, has published a Special Notice for a single-award, firm-fixed-price, indefinite-delivery/indefinite-quantity (IDIQ) contract with DiaSorin Inc. for the lease of three Liaison XL analyzers, installation, training, preventative maintenance, services/repairs, and all related reagents, consumables, and supplies.
The purpose of this Special Notice is to inform interested parties of the VA's intent to award this contract as a sole source procurement to DiaSorin Inc., as the Liaison XL is the only open-access, continuous-feed instrument capable of detecting latent Tuberculosis using an FDA-cleared assay. Interested parties may submit capability statements no later than May 20, 2024 at 10:00 AM CT. If no responses are received, a sole source award will be made to DiaSorin Inc. The contract will be awarded under NAICS code 325413 with a size standard of 1,250 employees.
Notice text
Special Notice
Special Notice
*= Required Field
Special Notice
Page 1 of 4
The Department of Veterans Affairs Medical Center, Network Contracting Office (NCO) 9, on behalf of Lexington Veterans Affairs Healthcare System (VAHS), 1101 Veterans Drive, Lexington, KY 40502-2235 Â hereby provides notice of its intent to establish a single award firm-fixed-price indefinite-delivery/indefinite-quantity (IDIQ) contract with five ordering periods to DiaSorin Inc. The contract will include the lease of one (3) Liaison XL analyzer, installation, training, preventative maintenance, services/repairs, and all reagents, consumables, and supplies.
The anticipated award is in accordance with FAR 13.106-1(b)(1), Soliciting from a Single Source. It is the Government's belief that the proposed candidate is the only provider of DiaSorin Liaison XL Analyzer services that can meet the agency's needs. DiaSorin Liaison XL is the only open-access, continuous Feed instrument capable of detecting latent Tuberculosis using an FDA-cleared assay.
In accordance with 38 U.S Code 8127 the Veteran s First Contracting Program, this requirement does not meet the Rule of Two. This requirement will be awarded using other than competitive procedures when such concern is determined to be a responsible source with fulfilling this requirement. The North American Industry Classification System (NAICS) code is 325413 and has a size standard of 1,250 employees for this procurement.
Other important considerations: Cite any other information that is necessary for potential respondents to understand the nature of the potential requirement or proposed acquisition.
Capability statement /information sought: Response to this announcement shall not to exceed 10 pages and should include the following information: (1) A tailored capability statement indicating the firm s ability to provide a product and related services; (2) The respondents DUNS number, organization name, address, point of contact, and size and type of business (e.g., SDVOSB/VOSB, etc,) pursuant to the applicable NAICS code; (3) Information should be provided electronically in a Microsoft Word or Adobe PDF format.
This notice of intent is not a request for competitive quotes. However, interested parties may identify their interest and capability to respond to the requirement and submit a capability statement no later than 10:00 am., CT, Monday, May 20, 2024 to: Christina.Lawrence2@va.gov. Responses received will be evaluated; however, a determination by the Government not to compete the proposed procurement based upon responses received to this notice is solely within the discretion of the Government. If no written response is received within the closing date of this notice, a sole source award will be made to DiaSorin Inc. without any further notice.
Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response to this notice. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. However, responses to this notice will not be considered adequate responses to a notice.
Attachments
| File | Type | Posted |
|---|---|---|
| P09-SOW-Liaison XL 3-21-24 Final.pdf | ||
| 36C24924Q0274.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6550--Diasorin Liaison XL Analyzer and Testing | Award Notice | |
| 6550--Diasorin Liaison XL Analyzer and Testing | Solicitation | |
| 6550--Diasorin Liaison XL Analyzer and Testing | Pre-Solicitation | |
| 6550--Diasorin Liaison XL Analyzer and Testing | Special Notice |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity